Tiotropium may reduce mortality in COPD patients

Monday, January 11th, 2010

Treatment with the long-acting anticholinergic tiotropium is associated with reduced all-cause and cardiovascular (CV)-related mortality in patients with chronic obstructive pulmonary disease (COPD), results from a systematic review show. Bartolome Celli (Brigham and Women’s Hospital, Boston, Massachusetts, USA) and colleagues reviewed safety data from 30 randomized, double-blind, parallel-group, placebo-controlled clinical trials of tiotropium with a […]